Skip to main content
. 2021 Sep 30;74(5):2580–2594. doi: 10.1002/hep.31992

TABLE 1.

Clinical Characteristics of All Patients

At Listing SBRT (n = 40) TACE (n = 59) HIFU (n = 51) P Value
Age (years) 59.6 (36‐69) 58.1 (42‐69) 59.5 (38‐68) 0.617
Sex, male, (n, %) 26 (65.0) 50 (84.7) 41 (80.4) 0.025
BMI (kg/m2) 26.1 (19.7‐41.9) 25.0 (18.1‐44.3) 24.0 (15.6‐34.1) 0.144
HBV (n, %) 34 (85.0) 45 (76.3) 41 (80.4) 0.287
HCV (n, %) 3 (7.5) 8 (13.6) 9 (17.6) 0.462
MELD at listing 13 (11‐15) 10 (9‐12) 12 (10‐16) <0.001
Child‐Turcotte‐Pugh (n, %) 0.001
Child A 21 (52.5) 36 (61.0) 17 (33.3)
Child B 19 (47.5) 21 (35.6) 22 (43.1)
Radiological tumor number (n, %) 0.136
1 28 (70.0) 33 (55.9) 40 (78.4)
2 8 (20.0) 19 (32.2) 9 (17.6)
3 4 (10.0) 7 (11.9) 2 (3.9)
Radiological tumor size (cm) 2.8 (1.1‐5.7) 2.2 (0.8‐6.3) 2.6 (0.7‐5.1) 0.072
Radiological within Milan (n, %) 33 (82.5) 52 (88.1) 48 (94.1) 0.491
AFP at listing (ng/mL) 9.5 (2‐11,772) 19.0 (2‐7,320) 15.0 (1‐159,370) 0.405
AFP at listing (n, %) 0.141
<200 ng/mL 34 (85.0) 43 (72.9) 41 (80.4)
≥200 ng/mL 6 (15.0) 16 (27.1) 10 (19.6)

Variables were presented as median (range) or number (percentage).

Abbreviation: BMI, body mass index.